Eye Movements Recording Using a Mobile : Comparison to Standard Video-oculography in Young Athletes
NCT ID: NCT05211752
Last Updated: 2022-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2022-01-18
2022-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography and Correlation to Imaging Data in Young Athletes
NCT05385601
Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography in Patients With Multiple Sclerosis
NCT04702763
Repeatability Assessment of Neurovisual Tasks for the Construction of a New Concussion Monitoring Tool (SPORTICARE)
NCT05992194
Visual Stimulus and Eye Movement
NCT00001172
Diagnostic Value of eVOG
NCT05776511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Memory Center of the Rainier III Center is expert in eye-tracking and is equipped with a standard video-oculography device (Eye-Tracker®T2), which records eye movements at a high frequency and measures saccades parameters (latency, speed, amplitudes etc...).
e-VOG is a mobile application, home-developed by the Neurology Department team of Nice University Hospital, to measure eye movements.
Based on literature, investigators hypothesize that video-oculography could integrate assessment protocols for head trauma occurring during sports practice. The nomadic nature of the e-VOG application would make possible to assess oculomotor behaviors to a subject who has just suffered a trauma and who is suspected of having a concussion.
From this perspective, it seems necessary to firstly validate baseline values of the e-VOG application in a population of athletes without major health problems, and who have not presented concussion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy young athletes (Eye-Tracker®T2 + e-VOG)
Subjects who first perform standard video-oculography assessment, followed by e-VOG digital assessment.
eVOG (Mobile VideoOculoGraphy)
* Eyes movements assessed with e-VOG (mobile application, that uses the face detection features of the front camera to detect and record eye movements).
* Study duration is about 20 minutes, the day the subject performs his standard video-oculography examination in routine care (using Eye-Tracker®T2)
Healthy young athletes (e-VOG + Eye-Tracker®T2)
Subjects who first perform e-VOG digital assessment, followed by the standard video-oculography assessment.
eVOG (Mobile VideoOculoGraphy)
* Eyes movements assessed with e-VOG (mobile application, that uses the face detection features of the front camera to detect and record eye movements).
* Study duration is about 20 minutes, the day the subject performs his standard video-oculography examination in routine care (using Eye-Tracker®T2)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
eVOG (Mobile VideoOculoGraphy)
* Eyes movements assessed with e-VOG (mobile application, that uses the face detection features of the front camera to detect and record eye movements).
* Study duration is about 20 minutes, the day the subject performs his standard video-oculography examination in routine care (using Eye-Tracker®T2)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* referred by AS Monaco Medical Team to perform a video-oculography (Eye-Tracking) examination as part of routine care.
* covered by a health insurance system
* volunteer, able to give free, informed and written consent.
* For minors: whose holder of parental authority has given their written consent to participate following the information given by investigator.
Exclusion Criteria
* Head trauma within 3 months
* Neurological, ophthalmological or general pathology preventing the realization of a video-oculography examination.
* Oculomotor abnormality detectable on clinical examination by the neurologist prescribing the standard video-oculography examination.
15 Years
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Princesse Grace
OTHER
Centre Hospitalier Universitaire de Nice
OTHER
Association Sportive Monaco Football Club
UNKNOWN
Association de Recherche Bibliographique pour les Neurosciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mikael COHEN, MD
Role: PRINCIPAL_INVESTIGATOR
Centre de Ressources et de Compétences SEP, UMRC Pasteur 2, Université Nice Côte d'Azur, Nice-France
Sandrine LOUCHART de la CHAPELLE, MD-PHD
Role: PRINCIPAL_INVESTIGATOR
Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital, Monaco
Alain PESCE, PUPH
Role: STUDY_DIRECTOR
Association de Recherche Bibliographique pour les Neurosciences
Sylvain BLANCHARD, MD-PHD
Role: PRINCIPAL_INVESTIGATOR
Association Sportive Monaco Football Club
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Mémoire / Centre de Gérontologie Clinique Rainier III / Princess Grace Hospital
Monaco, , Monaco
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
e-VOG Young Athletes
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.